A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Mise à jour : Il y a 4 ans
Référence : NCT01585233

Femme et Homme

Extrait

The purpose of this study is to explore the safety and tolerability of multiple doses of ASKP1240 compared to placebo and determine Pharmacokinetics and Pharmacodynamics in subjects with moderate to severe psoriasis.


Critère d'inclusion

  • Psoriasis

Liens